Q4 2025 and full year 2025 net product revenue of $202.1 million and $677.6 million, respectively –– ARCALYST 2026 net ...
Intralesional application of the MMR vaccine is more effective than vitamin D3 for the treatment of cutaneous, nongenital warts.
As looksmaxxing enters our lexicon, the practice of bonesmashing—tapping your face with a hammer to shape your bone structure—is trailing close behind.